EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieBeobachtungsstudie

Modification Procedures for Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS‐CTO Registry

Eleni Kladou iD, Dimitrios Strepkos iD, Michaella Alexandrou iD, Deniz Mutlu iD, Pedro E P Carvalho iD, Jaskanwal Deep Singh Sara, Ozgur Selim Ser iD, Khaldoon Alaswad, Mir B Basir, Dmitrii Khelimskii iD, Farouc A Jaffer, Nidal Abi Rafeh und 11 weitere

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70228 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Eleni Kladou und 22 weiteren Autor:innen. Beteiligte Einrichtung: Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Coronary Occlusion, Angioplasty, Balloon, Coronary, Percutaneous Coronary Intervention. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

CTO‐ARC (Chronic Total Occlusion Academic Research Consortium) defines CTO modification procedures (previously called investment procedures) as intentional balloon dilatation (diameter ≥ 2.0 mm) of the entire CTO, including the proximal and distal caps and the CTO body.

Aims

The aim of this study is to compare the outcomes of repeat CTO PCI between patients who underwent lesion modification during the initial failed procedure and those who did not.

Methods

We analyzed the association of CTO modification with the baseline clinical and angiographic characteristics and outcomes of 2829 patients, with a total of 2869 CTOs who underwent CTO percutaneous coronary intervention (PCI) after a previously failed attempt.

Results

CTO modification was performed in 600 of 2869 CTOs (20.9%) that underwent a repeat PCI attempt. CTOs that underwent modification had a higher prevalence of blunt/no stump (63.9% vs. 54.5%, p < 0.001), moderate/severe calcification (59.4% vs. 48.5%, p < 0.001), and moderate/severe proximal tortuosity (43.6% vs. 30.4%, p < 0.001). They also had longer length (38 vs. 31 mm, p < 0.001) and higher J‐CTO (3.69 vs. 3.21, p < 0.001) score. There was no statistically significant difference in technical (84.1% vs. 85.4%, p = 0.478) or procedural (82.7% vs. 84.2%, p = 0.403) success or major adverse cardiac events (MACE, 1.7% vs. 1.8%, p = 1.0) between the modification and no modification groups. Similarly, among patients who underwent CTO modification, there were no significant differences in outcomes between early ( < 60 days) and late ( ≥ 60 days) reattempts after the initial failure. Technical success was significantly higher after subintimal tracking and re‐entry (STAR) than subintimal plaque modification (SPM) (82.5% vs. 60.0%, p = 0.028).

Conclusions

CTO modification procedures were performed in approximately one of five CTO PCIs during the initial failed procedure. During reattempt CTO PCI, despite higher lesion complexity, CTO modification was associated with similar technical and procedural success and MACE compared to patients undergoing reattempt CTO PCI without prior CTO modification. Among modification techniques, STAR was associated with higher technical and procedural success than SPM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary OcclusionAngioplasty, Balloon, CoronaryPercutaneous Coronary InterventionHumansRegistriesMaleFemaleChronic DiseaseAgedMiddle AgedTreatment OutcomeTime FactorsRisk FactorsCoronary AngiographyRisk AssessmentRetrospective Studies

Stichwörter der Autor:innen

chronic total occlusionmodification procedurepercutaneous coronary intervention

Autor:innen und Institutionen

  • Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.
  • Henry Ford Cardiovascular Division, Detroit, Michigan, USA.
  • Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.
  • Massachusetts General Hospital, Boston, Massachusetts, USA.
  • North Oaks Health System, Hammond, Louisiana, USA.
  • Oklahoma Heart Institute, Tulsa, Oklahoma, USA.

ORCID-Profile: Eleni Kladou, Dimitrios Strepkos, Michaella Alexandrou, Deniz Mutlu, Pedro E P Carvalho, Ozgur Selim Ser, Dmitrii Khelimskii, Olga Mastrodemos, Sandeep Jalli

Zitieren

APA

Kladou, E., Strepkos, D., Alexandrou, M., Mutlu, D., Carvalho, P. E. P., Sara, J. D. S., Ser, O. S., Alaswad, K., Basir, M. B., Khelimskii, D., Jaffer, F. A., Rafeh, N. A., Chandwaney, R., Cevik, C., Ahmad, Y., Mastrodemos, O., Rangan, B. V., Jalli, S., Voudris, K., …, & PROGRESS‐CTO Investigators (2025). Modification Procedures for Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS‐CTO Registry. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70228

Vancouver

Kladou E, Strepkos D, Alexandrou M, Mutlu D, Carvalho PEP, Sara JDS, et al. Modification Procedures for Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS‐CTO Registry. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70228

BibTeX
@article{Kladou2025,
  author = {Kladou, Eleni and Strepkos, Dimitrios and Alexandrou, Michaella and Mutlu, Deniz and Carvalho, Pedro E P and Sara, Jaskanwal Deep Singh and Ser, Ozgur Selim and Alaswad, Khaldoon and Basir, Mir B and Khelimskii, Dmitrii and Jaffer, Farouc A and Rafeh, Nidal Abi and Chandwaney, Raj and Cevik, Cihan and Ahmad, Yousif and Mastrodemos, Olga and Rangan, Bavana V and Jalli, Sandeep and Voudris, Konstantinos and Sandoval, Yader and Nicholas Burke, M and Brilakis, Emmanouil S and PROGRESS‐CTO Investigators, PROGRESS‐CTO Investigators},
  title = {Modification Procedures for Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS‐CTO Registry},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70228}
}
Kostenlos starten →